We recently compiled a list of the 12 Best International Dividend Stocks To Buy Now. In this article, we are going to take a ...
Commenting on the Champions Initiative, Cradle co-founder and chief executive Stef van Grieken said that technological ...
Bernstein analysts led by Florent Cespedes increased their price target on Novo Nordisk (NOVOB:DC) (NYSE: NYSE:NVO) stock to DKK620.00, up from DKK600.00, while maintaining a Market Perform rating.
On today's Market Minute, Yahoo Finance's Seana Smith highlights the top-moving stocks in Wednesday's trading session. Super ...
Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data ...
Novo Nordisk A/S investors got a much-needed boost from last week’s trial results for an experimental weight-loss shot. But ...
On the charts, today's pop has NVO on track to snap a three-day losing streak. The stock still hasn't recovered from its ...
The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower ...
Novo Nordisk reported strong data for its next-gen anti-obesity medicine. The Danish company has an excellent weight loss drug pipeline. But it's also diversifying its lineup and offering other perks.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results